(Reuters) – Oxford University and AstraZeneca Plc have begun work to produce an Omicron-targeted version of their coronavirus vaccine, the Financial Times reported on Tuesday.
(Reporting by Maria Ponnezhath in Bengaluru; Editing by Leslie Adler)
(Reuters) – Oxford University and AstraZeneca Plc have begun work to produce an Omicron-targeted version of their coronavirus vaccine, the Financial Times reported on Tuesday.
(Reporting by Maria Ponnezhath in Bengaluru; Editing by Leslie Adler)